DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Micardis HCT (Telmisartan / Hydrochlorothiazide) - Summary

 

-- advertisement --

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, MICARDIS® HCT (telmisartan/hydrochlorothiazide) tablets should be discontinued as soon as possible (see WARNINGS, Fetal/Neonatal Morbidity and Mortality).

 

MICARDIS HCT SUMMARY

Micardis® HCT
(telmisartan and hydrochlorothiazide)
Tablets, 40mg/12.5 mg
80 mg/12.5 mg and 80 mg/25 mg

MICARDIS® HCT (telmisartan/hydrochlorothiazide) is a combination of telmisartan, an orally active angiotensin II antagonist acting on the AT1 receptor subtype, and hydrochlorothiazide, a diuretic.

MICARDIS® HCT (telmisartan/hydrochlorothiazide) is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy (see DOSAGE AND ADMINISTRATION).

MICARDIS HCT NEWS HIGHLIGHTS

Media Articles Related to Micardis HCT (Telmisartan / Hydrochlorothiazide)

GP-Led Hypertension Health Promotion Campaign Delivers Response Rates Of 76%
Source: Hypertension News From Medical News Today [2008.08.21]

Hypertension May Result From Poor Teen Sleep Habits, Lead To CVD
Source: Cardiovascular / Cardiology News From Medical News Today [2008.08.20]

Poor Sleep May Lead to Hypertension in Teens
Source: MedPage Today Cardiovascular [2008.08.18]

Better Hypertension Treatment By Determining How The Body Regulates Blood Pressure In Response To Daily Stress
Source: Hypertension News From Medical News Today [2008.08.16]

Tracleer(R) (bosentan) Receives EU Approval For Treatment Of Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
Source: Hypertension News From Medical News Today [2008.08.04]

more>>

Published Studies Related to Micardis HCT (Telmisartan / Hydrochlorothiazide)

Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. [2008.02]

Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2006.03]

The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial. [2005.11]

Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension. [2005.07]

Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. [2005.05]

more>>

Clinical Trials Related to Micardis HCT (Telmisartan / Hydrochlorothiazide)

Telmisartan80mg/hydrochlothiazide12.5mg (Micardis Plus) ABPM Study in China [Completed]

INNOVATION Study - Telmisartan (Micardis?) in Incipient Diabetic Nephropathy [Completed]

Telmisartan80/HCTZ25 Versus telmisartan80/HCTZ12.5 in Hypertension Not Responding to telmisartan80/HCTZ12.5 [Completed]

Trial of Telmisartan 80mg/HCTZ 12.5mg and Telmisartan 40mg/HCTZ 12.5mg in Patients With Hypertension [Completed]

Non-Responder Study to Telmisartan 40mg [Completed]

more>>

Page last updated: 2008-08-21

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008